SunGen Pharma, a privately held specialty pharmaceutical company, has launched and started commercial shipment of a generic version of Bentyl (Dicyclomine) Injection in the United States, it was reported on Friday.

The product has been launched in collaboration with Camber Pharmaceuticals as SunGen's distribution and marketing partner.

Dicyclomine Hydrochloride Injection USP, 20mg/2mL (10mg/mL) is a sterile injectable in a two ml-vial. It is used to treat patients with severe irritable bowel syndrome and bowel spasms. It had total US sales of USD17m for 2018 according to IQVIA.